Unquote

Idia et al. back Le Groupe Bioclinic in SBO

  • Francesca Veronesi
  • Francesca Veronesi
  • LinkedIn  
  • Google plus  

A consortium of investors has backed France-based medical analysis laboratory Le Groupe Bioclinic, investing alongside founder Philippe Dabi.

Idia Capital Investissement, Amundi Private Equity Funds, Socadif and Andera Partnershave backed Bioclinic. Andera used its €315m ActoMezz III fund for the investment. 

GPs, together, have acquired a minority stake of less than 35%, Unquote understands. 

Debt for the transaction was provided by LCL.

Founding president Philippe Dabi, the majority shareholder since 1995, sees his majority stake in the business increase. The management team has also retained a stake in Bioclinic.

The consortium is planning to accelerate Bioclinic's growth via several new acquisitions.

Previous funding
Azulis Capital and Galia Gestion have held stakes in the business since 2011. During their ownership, the company bolted on 34 sites. The most recent transaction sees the two GPs exit the investment.

Company
Founded in 1995 by Philippe Dabi, the Bioclinic group is a medical biology company that has grown via the acquisition of existing laboratories and of market share in healthcare facilities. Today Bioclinic operates 60 sites in the Paris region.

The business generates a turnover of approximately €40m, Unquote understands.  

People
Bioclinic – Philippe Dabi (founder).
Idia Capital Investissement – Delphine Pavy (investment manager).  
Amundi Private Equity Funds – Romain Bled (partner).
Andera Partners – Arnaud Faure (partner); Christine Martinovic (investment director); Pierre-Luc Wilain de Leymarie (investment associate).
Azulis Capital – Christine Mariette (managing partner); Julien Hess (investment director).
Galia Gestion – Claudia Daugan (investment director).
Socadif – Luis Batista (investment director).

Advisers
Equity – De Pardieu, Jean-François Pourdieu, Matthieu Candia, Alexandre Bankowski, Priscilla Van Den Perre, Chloé Herbert (legal, tax); Oderis, Julien Passerat, Julien Louis, Eddy Chagué (financial due diligence).
Management – Lamartine, Fabien Mauvais, Philippe Barouch, Emma Thibaud (legal, tax).
Vendor – Accuracy, Arnaud Lambert, Vivien Thirard (financial due diligence); Crédit Agricole Corporate & Investment Banking, Kristelle Kerforn, Samuel Knossow, François Armand (corporate finance).

  • LinkedIn  
  • Google plus  

More on Buyouts

Latest News